Form 4: Royalty Pharma EVP & CFO Terrance P. Coyne Reports Charitable Donation of ICAI Interests

Terrance P. Coyne, EVP & CFO of Royalty Pharma plc, reports a charitable donation of ICAI Interests, which are exchangeable for Class A Ordinary Shares, according to a Form 4 filing.

Summary

• Terrance P. Coyne, the EVP & CFO of Royalty Pharma plc, filed a Form 4 indicating a change in beneficial ownership.
• The reported transaction involves a charitable donation of 2,000 ICAI Interests by Coyne on August 12, 2024.
• These ICAI Interests represent a grant of an equivalent number of limited partnership interests in RPI US Partners 2019, LP, which can be exchanged for Class B Interests in Royalty Pharma Holdings Limited, and subsequently for Class A Ordinary Shares of Royalty Pharma plc.
• The filing also notes that Coyne and family vehicles controlled by him hold 840,390 Class A Ordinary Shares and RPI US LP Interests exchangeable into 2,964,680 Class A Ordinary Shares.

Sentiment

Score: 6

Explanation: The document is a routine filing related to a charitable donation. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Positives

• The charitable donation does not involve a sale of Class A Ordinary Shares, RPI US LP Interests, or ICAI Interests.

Industry Context

Form 4 filings are standard practice for company insiders to report changes in their beneficial ownership of company securities, providing transparency to the market.

Stakeholder Impact

• The charitable donation has a minimal direct impact on stakeholders.

Key Dates